The authors have no conflicts of interest to disclose.
Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma
Article first published online: 21 NOV 2013
© 2013 American Association for the Study of Liver Diseases
Volume 20, Issue 1, pages 81–88, January 2014
How to Cite
Welling, T. H., Feng, M., Wan, S., Hwang, S. Y., Volk, M. L., Lawrence, T. S., Zalupski, M. M. and Sonnenday, C. J. (2014), Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma. Liver Transpl, 20: 81–88. doi: 10.1002/lt.23757
This work was partially supported by the Tissue Histology Core and Tumor Procurement Program (Comprehensive Cancer Center) and the National Institutes of Health (grant CA151414 to Theodore H. Welling).
- Issue published online: 20 DEC 2013
- Article first published online: 21 NOV 2013
- Accepted manuscript online: 1 OCT 2013 01:46PM EST
- Manuscript Accepted: 13 SEP 2013
- Manuscript Received: 11 JUL 2013
Additional Supporting Information may be found in the online version of this article.
|lt23757-sup-0001-suppfig1.TIF||2725K||Supporting Information Figure 1. Flowchart depicting patients evaluated, initiated on therapy, and transplant status. The patients that were ruled out before entering the protocol or were removed following initiation of therapy at the time of staging laparoscopy are also indicated. Additional patient details are provided in Table 2 and in the text.|
|lt23757-sup-0002-suppfig2.TIF||1194K||Supporting Information Figure 2. Proliferative and apoptotic rates for individual patients after neoadjuvant therapy. Proliferative index (PI) and apoptotic index (AI) was determined as described in Fig. 3 on neoadjuvant therapy patients (top) and on non-treated surgically resected patients (bottom).|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.